Hims & Hers Health (HIMS) investor relations material

Strategic vision and growth targets

• Aims to transform healthcare by leveraging a closed-loop ecosystem, expanding specialties, and pursuing international growth.

• Set ambitious 2030 targets: $6.5 billion in revenue and $1.3 billion in adjusted EBITDA, driven by global expansion, specialty broadening, and partnerships.

• Recent acquisition of Eucalyptus, with a $450 million run-rate and triple-digit growth, accelerates global reach and cultural alignment.

• Focused on integrating recent acquisitions and scaling international operations, especially in Australia, Canada, the U.K., and Germany.

• Investment priorities include technology, AI, and consumer experience, aiming for market leadership in each specialty.

Operational execution and investment cycle

• Investments are aimed at long-term yield, prioritizing market leadership and positive free cash flow.

• International operations expected to run at break-even near term, with future profit generation as scale is achieved.

• Technology and AI investments have enabled rapid specialty launches and improved platform efficiency.

• Capital allocation prioritizes durable growth, with flexibility for shareholder returns via buybacks when appropriate.

• M&A remains opportunistic but highly strategic, with current focus on integrating and maximizing value from recent deals.

Competitive advantages and platform differentiation

• Competitive moat built on infrastructure, scale, global reach, provider network, and brand trust.

• Rich dataset and technology talent enable personalized care and continuous platform improvement.

• Platform approach allows consumers to engage across multiple specialties, deepening retention and data insights.

• AI is used to drive cost efficiencies, enhance consumer experience, and support new product development.

• Brand trust and operational excellence are key differentiators in a rapidly evolving, AI-driven market.